Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synapse Biomedical has commercialized the NeuRx Diaphragm Pacing System®, an FDA-approved neurostimulation device that reduces or eliminates dependence on mechanical ventilators in patients with chronic respiratory insufficiency due to spinal cord injury or ALS. The company also develops additional neurostimulation products targeting ventilator-induced diaphragm dysfunction and post-stroke upper limb rehabilitation. Clinical data support improved patient comfort, reduced ventilator reliance, and enhanced functional outcomes in targeted populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synapse Biomedical.